Side-by-side financials for BTAI and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BTAI | NVS |
|---|---|---|
| Market cap | - | $293.12 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $642.00K | - |
| Net income (latest FY) | -$69.90M | - |
| Net margin | -10887.4% | - |
| SEC filings | 656 | 947 |
Full pages: BioXcel Therapeutics, Inc. and Novartis AG, or browse the full rankings.